---
figid: PMC7746821__fcell-08-580140-g001
figlink: pmc/articles/PMC7746821/figure/F1/
number: F1
caption: Summary of drug resistance in tumor immunotherapy. The mechanisms of drug
  resistance and immune escape in tumor immunotherapy include tumor cell-internal
  and -external factors. The internal factors include loss of tumor antigens and intratumor
  heterogeneity, defects in antigen presentation, abnormal oncogenic signaling and
  IFN-γ signal pathway, innate anti-PD-1 resistance signature, increased expression
  of constitutive PD-L1, epigenetic changes, and lack or exhaustion of T cells. The
  external factors include immunosuppressive cells and cytokines in tumor microenvironment,
  tumor metabolites in immune microenvironment, new immune checkpoints, and intestinal
  microflora. PD-1, programmed death 1; PD-L1, programmed death ligand 1; Anti, Anti-PD1/anti-PDL1;
  HLA, human leukocyte antigen; TCR, T-cell receptor; IFN-γ, interferon-γ; IFN-γR,
  Interferon-γ receptor; Treg, regulatory T cell; Neuropilin-1, neurociliary protein
  1; TAM, tumor associated macrophage; CSF-1, macrophage colony stimulating factor;
  MDSC, myelogenous suppressor cell; IL-6, interleukin-6; TGF-β, transforming growth
  factor-β; TNF, tumor necrosis factor.
pmcid: PMC7746821
papertitle: A Highlight of the Mechanisms of Immune Checkpoint Blocker Resistance.
reftext: Qian Huang, et al. Front Cell Dev Biol. 2020;8:580140.
pmc_ranked_result_index: '10723'
pathway_score: 0.9318264
filename: fcell-08-580140-g001.jpg
figtitle: Summary of drug resistance in tumor immunotherapy
year: '2020'
organisms:
- Mus musculus
- Akkermansia muciniphila
- Escherichia coli
- gut metagenome
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7746821__fcell-08-580140-g001.html
  '@type': Dataset
  description: Summary of drug resistance in tumor immunotherapy. The mechanisms of
    drug resistance and immune escape in tumor immunotherapy include tumor cell-internal
    and -external factors. The internal factors include loss of tumor antigens and
    intratumor heterogeneity, defects in antigen presentation, abnormal oncogenic
    signaling and IFN-γ signal pathway, innate anti-PD-1 resistance signature, increased
    expression of constitutive PD-L1, epigenetic changes, and lack or exhaustion of
    T cells. The external factors include immunosuppressive cells and cytokines in
    tumor microenvironment, tumor metabolites in immune microenvironment, new immune
    checkpoints, and intestinal microflora. PD-1, programmed death 1; PD-L1, programmed
    death ligand 1; Anti, Anti-PD1/anti-PDL1; HLA, human leukocyte antigen; TCR, T-cell
    receptor; IFN-γ, interferon-γ; IFN-γR, Interferon-γ receptor; Treg, regulatory
    T cell; Neuropilin-1, neurociliary protein 1; TAM, tumor associated macrophage;
    CSF-1, macrophage colony stimulating factor; MDSC, myelogenous suppressor cell;
    IL-6, interleukin-6; TGF-β, transforming growth factor-β; TNF, tumor necrosis
    factor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IL6
  - TNF
  - TRA
  - TRB
  - TRD
  - TRG
  - TGFB1
  - TGFB2
  - TGFB3
  - CSF1
  - CD274
  - PDCD1
  - LAG3
  - HAVCR2
  - ADAR
  - TIGIT
  - PBRM1
  - ATM
  - PTPN2
  - CD47
  - CD24
  - TCR
  - TAM
  - NKG2A
  - tumor
  - intra-tumor
genes:
- word: IL-6
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: TNF
  symbol: TNF
  source: hgnc_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRA
  entrez: '6955'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRB
  entrez: '6957'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRD
  entrez: '6964'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRG
  entrez: '6965'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
- word: CSF-1
  symbol: CSF1
  source: hgnc_symbol
  hgnc_symbol: CSF1
  entrez: '1435'
- word: PD-L1
  symbol: PD-L1
  source: hgnc_alias_symbol
  hgnc_symbol: CD274
  entrez: '29126'
- word: PD-1
  symbol: PD-1
  source: hgnc_alias_symbol
  hgnc_symbol: PDCD1
  entrez: '5133'
- word: LAG-3.
  symbol: LAG3
  source: hgnc_symbol
  hgnc_symbol: LAG3
  entrez: '3902'
- word: TIM-3.
  symbol: TIM3
  source: hgnc_alias_symbol
  hgnc_symbol: HAVCR2
  entrez: '84868'
- word: ADAR1.
  symbol: ADAR1
  source: hgnc_alias_symbol
  hgnc_symbol: ADAR
  entrez: '103'
- word: TIGIT.
  symbol: TIGIT
  source: hgnc_symbol
  hgnc_symbol: TIGIT
  entrez: '201633'
- word: PBRM1
  symbol: PBRM1
  source: hgnc_symbol
  hgnc_symbol: PBRM1
  entrez: '55193'
- word: ATM.
  symbol: ATM
  source: hgnc_symbol
  hgnc_symbol: ATM
  entrez: '472'
- word: Ptpn2.
  symbol: PTPN2
  source: hgnc_symbol
  hgnc_symbol: PTPN2
  entrez: '5771'
- word: CD47
  symbol: CD47
  source: hgnc_symbol
  hgnc_symbol: CD47
  entrez: '961'
- word: CD24
  symbol: CD24
  source: hgnc_symbol
  hgnc_symbol: CD24
  entrez: '100133941'
- word: PD-L1
  symbol: PD-L1
  source: hgnc_alias_symbol
  hgnc_symbol: CD274
  entrez: '29126'
chemicals:
- word: TCR
  source: MESH
  identifier: D017260
- word: TAM
  source: MESH
  identifier: C419191
- word: NKG2A
  source: MESH
  identifier: C075005
diseases:
- word: tumor
  source: MESH
  identifier: D009369
- word: intra-tumor
  source: MESH
  identifier: D009369
figid_alias: PMC7746821__F1
redirect_from: /figures/PMC7746821__F1
figtype: Figure
---
